miR‑576‑3p/M‑phase phosphoprotein 8 axis regulates the malignant progression of hepatocellular carcinoma cells via the PI3K/Akt signaling pathway.

Publisher: Spandidos Publications] Country of Publication: Greece NLM ID: 101531236 Publication Model: eCollection Cited Medium: Internet ISSN: 1792-1082 (Electronic) Linking ISSN: 17921074 NLM ISO Abbreviation: Oncol Lett Subsets: PubMed not MEDLINE

Original Publication: [Athens : Spandidos Publications]

Hepatocellular carcinoma (HCC) is a fatal digestive system cancer with unclear pathogenesis. M-phase phosphoprotein 8 (MPP8) has been shown to play a vital role in several cancer types, such as non-small cell lung cancer, gastric cancer and melanoma; however, there have been no studies into its role in HCC. The present study aimed to evaluate the role of MPP8 in regulating malignant phenotypes of liver cancer cells, and to further investigate the underlying mechanism. Bioinformatics analysis was performed to analyze related data from a public database, and to predict the potential microRNAs (miRNAs) that might target MPP8 mRNA; reverse transcription-quantitative PCR was used to measure the levels of mRNA and miRNA; western blotting was employed to detect protein levels; Cell Counting Kit-8 (CCK-8) and plate colony formation assays, wound healing assay and Transwell invasion assay were performed to evaluate the ability of cell proliferation, migration and invasion, respectively; dual-luciferase reporter gene assay was performed to identify the target association. The results showed that MPP8 was a risk factor for the survival of patients with HCC, and was up-regulated in HCC tissue samples and cell lines; MPP8 knockdown inhibited the proliferation, migration and invasion of liver cancer cells; MPP8 knockdown suppressed the PI3K/Akt pathway, and activation of this pathway reversed the inhibited liver cancer cell phenotypes by down-regulating MPP8; miR-576-3p, which was low in liver cancer cells, negatively regulated MPP8 expression by directly targeting its mRNA; up-regulating MPP8 expression reversed the inhibited signaling pathway and malignant phenotypes of liver cancer cells by miR-576-3p overexpression. In conclusion, the miR-576-3p/MPP8 axis regulates the proliferation, migration, and invasion of liver cancer cells through the PI3K/Akt signaling pathway. These findings lead novel insights into HCC progression, and propose MPP8 as a potential therapeutic target for HCC.
Competing Interests: The authors declare that they have no competing interests.
(Copyright: © 2024 Zhang et al.)

Ann Surg. 2015 May;261(5):947-55. (PMID: 25010665)
EMBO J. 2010 Nov 3;29(21):3673-87. (PMID: 20871592)
Front Oncol. 2022 May 30;12:817192. (PMID: 35712504)
J Cell Biochem. 2020 Mar;121(3):2330-2342. (PMID: 31692032)
Semin Cell Dev Biol. 2004 Apr;15(2):177-82. (PMID: 15209377)
Oncogene. 2011 Jun 16;30(24):2753-66. (PMID: 21297666)
Nucleic Acids Res. 2020 Jan 8;48(D1):D127-D131. (PMID: 31504780)
N Engl J Med. 1996 Mar 14;334(11):693-9. (PMID: 8594428)
Cell. 2009 Jan 23;136(2):215-33. (PMID: 19167326)
Mol Biol Cell. 1996 Sep;7(9):1455-69. (PMID: 8885239)
Mol Med Rep. 2016 Mar;13(3):2401-8. (PMID: 26847170)
Methods. 2001 Dec;25(4):402-8. (PMID: 11846609)
Oncol Lett. 2018 Nov;16(5):6531-6539. (PMID: 30405792)
Mol Cancer Res. 2019 Jan;17(1):289-298. (PMID: 30257988)
Nat Rev Cancer. 2002 Jul;2(7):489-501. (PMID: 12094235)
Liver Cancer. 2016 Nov;6(1):16-26. (PMID: 27995084)
Biomedicines. 2021 Nov 08;9(11):. (PMID: 34829868)
Mol Biotechnol. 2023 Jan;65(1):61-71. (PMID: 35794450)
Mol Cells. 2015;38(2):130-7. (PMID: 25556372)
BMC Cancer. 2020 Apr 6;20(1):282. (PMID: 32252678)
PLoS One. 2011;6(10):e25104. (PMID: 22022377)
Anticancer Drugs. 2021 Sep 1;32(8):812-821. (PMID: 34102651)
Biochem Biophys Res Commun. 2015 Mar 13;458(3):470-475. (PMID: 25660450)
Genes Dis. 2020 Jan 27;7(3):308-319. (PMID: 32884985)
Int J Clin Exp Pathol. 2017 Dec 01;10(12):12003-12009. (PMID: 31966565)
Science. 2015 Jun 26;348(6242):1481-1485. (PMID: 26022416)
Cell. 2004 Jan 23;116(2):281-97. (PMID: 14744438)
Neoplasia. 2022 Mar;25:18-27. (PMID: 35078134)
Hepatology. 2013 May;57(5):2072-7. (PMID: 23150189)
Radiology. 2015 May;275(2):438-47. (PMID: 25531387)
Elife. 2015 Aug 12;4:. (PMID: 26267216)
Cell Mol Biol (Noisy-le-grand). 2018 Jan 31;64(1):27-31. (PMID: 29412790)

Keywords: M-phase phosphoprotein 8; PI3K/Akt pathway; hepatocellular carcinoma; malignant phenotype; miR-576-3p

Date Created: 20240529 Latest Revision: 20240530

20240530

PMC11130756

10.3892/ol.2024.14460

38807669